Crescita Therapeutics Inc. (TSX:CTX)
Canada
· Delayed Price · Currency is CAD 0.450
-0.010 (-2.17%)
At close: Mar 6, 2026
Crescita Therapeutics Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 8.31 | 9.27 | 9.39 | 8.24 | 11.33 | 14.28 | Upgrade
|
| Short-Term Investments | - | 0 | 0 | 0.07 | 0.08 | 0.06 | Upgrade
|
| Cash & Short-Term Investments | 8.31 | 9.28 | 9.39 | 8.31 | 11.41 | 14.34 | Upgrade
|
| Cash Growth | -1.54% | -1.19% | 12.97% | -27.17% | -20.44% | 53.74% | Upgrade
|
| Accounts Receivable | 1.91 | 1.58 | 2.75 | 6.14 | 3.6 | 1.22 | Upgrade
|
| Other Receivables | - | 0.13 | 0.02 | 0.1 | 0.15 | 0.2 | Upgrade
|
| Receivables | 1.91 | 1.72 | 2.78 | 6.24 | 3.75 | 1.42 | Upgrade
|
| Inventory | 5.36 | 4.05 | 6.13 | 5.65 | 4.39 | 3.46 | Upgrade
|
| Prepaid Expenses | - | 0.26 | 0.2 | 0.32 | 0.54 | 0.24 | Upgrade
|
| Other Current Assets | 0.4 | - | - | - | - | - | Upgrade
|
| Total Current Assets | 15.99 | 15.3 | 18.49 | 20.52 | 20.09 | 19.45 | Upgrade
|
| Property, Plant & Equipment | 2.12 | 2.42 | 1.85 | 2.31 | 2.58 | 0.79 | Upgrade
|
| Long-Term Investments | - | 0.31 | 0.36 | 0.34 | 0.34 | - | Upgrade
|
| Other Intangible Assets | 1.63 | 1.74 | 1.99 | 2.87 | 3.74 | 4.61 | Upgrade
|
| Long-Term Accounts Receivable | 1.42 | 1.39 | 1.48 | 1.57 | 1.66 | 1.98 | Upgrade
|
| Long-Term Deferred Tax Assets | - | - | - | 0.46 | - | - | Upgrade
|
| Total Assets | 21.46 | 21.78 | 24.6 | 28.48 | 28.92 | 26.83 | Upgrade
|
| Accounts Payable | 4.59 | 5 | 4.33 | 5.59 | 5.33 | 4.27 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | 0.98 | - | Upgrade
|
| Current Portion of Leases | 0.48 | 0.47 | 0.44 | 0.41 | 0.37 | 0.3 | Upgrade
|
| Other Current Liabilities | 0.05 | 0.05 | 0.1 | 0.06 | 0.06 | 0.05 | Upgrade
|
| Total Current Liabilities | 5.12 | 5.52 | 4.86 | 6.06 | 6.73 | 4.62 | Upgrade
|
| Long-Term Debt | - | - | - | - | - | 0.93 | Upgrade
|
| Long-Term Leases | - | 0.37 | 0.82 | 1.21 | 1.53 | - | Upgrade
|
| Other Long-Term Liabilities | 0.08 | 0.07 | 0.1 | 0.12 | 0.15 | 0.15 | Upgrade
|
| Total Liabilities | 5.2 | 5.95 | 5.78 | 7.39 | 8.4 | 5.7 | Upgrade
|
| Common Stock | 51.49 | 52.7 | 54.34 | 56.3 | 58.08 | 58.18 | Upgrade
|
| Additional Paid-In Capital | 8.4 | 7.37 | 5.96 | 4.27 | 2.77 | 2.27 | Upgrade
|
| Retained Earnings | -44.73 | -45.35 | -42.6 | -40.61 | -41.48 | -40.37 | Upgrade
|
| Comprehensive Income & Other | 1.1 | 1.11 | 1.12 | 1.13 | 1.15 | 1.05 | Upgrade
|
| Shareholders' Equity | 16.26 | 15.83 | 18.82 | 21.1 | 20.53 | 21.13 | Upgrade
|
| Total Liabilities & Equity | 21.46 | 21.78 | 24.6 | 28.48 | 28.92 | 26.83 | Upgrade
|
| Total Debt | 0.48 | 0.83 | 1.25 | 1.61 | 2.87 | 1.23 | Upgrade
|
| Net Cash (Debt) | 7.82 | 8.44 | 8.13 | 6.7 | 8.54 | 13.11 | Upgrade
|
| Net Cash Growth | 4.15% | 3.79% | 21.46% | -21.60% | -34.85% | 68.51% | Upgrade
|
| Net Cash Per Share | 0.41 | 0.44 | 0.40 | 0.32 | 0.41 | 0.63 | Upgrade
|
| Filing Date Shares Outstanding | 18.61 | 19.01 | 19.54 | 20.33 | 20.9 | 20.62 | Upgrade
|
| Total Common Shares Outstanding | 18.61 | 19.08 | 19.96 | 20.33 | 20.98 | 20.65 | Upgrade
|
| Working Capital | 10.86 | 9.79 | 13.62 | 14.46 | 13.37 | 14.84 | Upgrade
|
| Book Value Per Share | 0.87 | 0.83 | 0.94 | 1.04 | 0.98 | 1.02 | Upgrade
|
| Tangible Book Value | 14.63 | 14.09 | 16.83 | 18.23 | 16.79 | 16.52 | Upgrade
|
| Tangible Book Value Per Share | 0.79 | 0.74 | 0.84 | 0.90 | 0.80 | 0.80 | Upgrade
|
| Machinery | - | 3.59 | 2.68 | 2.56 | 2.32 | 1.97 | Upgrade
|
| Leasehold Improvements | - | 0.62 | 0.62 | 0.62 | 0.62 | 0.62 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.